Notably, MMRN1‐high expression was more prevalent in T3/T4‐stage RCC patients (n = 27), suggesting its predominant role in metastatic progression with secondary effects on cellular proliferation. This evidence concerns the gene MMRN1 and renal cell carcinoma.